Unrecognised systemic hypertension in patients with obstructive sleep apnoea

M. Trefny, Z. Susa, P. Celakovsky, Z. Trefny (Prague, Czech Republic)

Source: Annual Congress 2006 - Pathogenesis of obstructive sleep apnoea
Session: Pathogenesis of obstructive sleep apnoea
Session type: Thematic Poster Session
Number: 3751
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Trefny, Z. Susa, P. Celakovsky, Z. Trefny (Prague, Czech Republic). Unrecognised systemic hypertension in patients with obstructive sleep apnoea. Eur Respir J 2006; 28: Suppl. 50, 3751

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Unrecognised hypertension in patients screened for obstructive sleep apnoea
Source: Eur Respir J 2005; 26: Suppl. 49, 40s
Year: 2005

Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009


Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease
Source: Eur Respir J 2013; 41: 616-620
Year: 2013



Prevalence of obstructive sleep apnea among patients with resistant arterial hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 115s
Year: 2005

Chronic obstructive pulmonary disease in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009

Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009

Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience
Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new?
Year: 2020


Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012


Prevalence of obstructive airway disease in patients with obstructive sleep apnea
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012

Arterial hypertension in patients with obstructive sleep apnea syndrome in cluj napoca, Romania
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009

Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006

Efficacy of AUTO-CPAP titration in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 390s
Year: 2001

Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019

Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease.
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Resistant arterial hypertension and obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012

Cardiac arrythmias in chronic obstructive pulmonary disease and obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 645s
Year: 2006

Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Source: Guidelines 2013
Year: 2013

Glaucoma and ocular hypertension in obstructive sleep apnea patients
Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea
Year: 2007